Menu

Concert Pharmaceuticals, Inc. CNCE

Full chart Compare
Set alert

Price alert · CNCE

All alert types
8.37 +8.37

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Other Revenue → Revenue: $32.54MRevenue → Gross Profit: $32.58MGross Profit → Expenses: $32.58MExpenses → Selling, General & Admin: $22.25MExpenses → Research & Development: $87.56MExpenses → Other Operating Expenses: $283.00KExpenses → Other Expenses: $2.54MExpenses → Income Tax: $2.54MLicense And Research And Development Revenue → Revenue: $39.00KNet Loss → Expenses: $82.59MGross Profit$32.58MNet Loss$82.59MExpenses$115.17MSelling, General & Admin$22.25MResearch & Development$87.56MOther Operating Expenses$283.00KOther Expenses$2.54MIncome Tax$2.54MRevenue$32.58MOther Revenue$32.54MLicense And Research And Development Revenue$39.00K

Latest period ending Dec 31, 2021 · select a line to chart its full history

CNCE annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
32.58M7.90M1.08M10.51M143.89M
32.58M7.90M1.08M10.51M143.89M
-77.51M-72.65M-79.02M-55.58M92.65M
-80.05M-74.77M-78.17M-56.02M95.19M
-2.33-2.40-3.29-2.404.06
CNCE annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
142.79M78.36M54.20M18.93M29.22M
165.32M159.26M137.47M192.55M211.74M
53.09M28.10M36.01M24.81M15.30M
13.91M15.06M16.00M00
112.22M131.16M101.46M167.74M196.43M
CNCE annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
-55.15M-69.04M-48.76M-48.03M104.08M
52.46M344.00K82.58M37.90M-121.31M
67.13M92.85M1.45M-169.00K5.49M
-255.00K-210.00K-685.00K-2.87M-947.00K
64.43M24.16M35.27M-10.29M-11.73M